At this point in time its a race to the bottom between the two of them... I was pretty sure that TCON would have had another deal to announce... a company as large as the one that paid 3 million dollars for their technology should have opened some doors for new biotech's to want to buy this technology. Apparently not, as it has just been sitting there and they all seem to be on vacation at the company.
It is very difficult when you actually believe that this will get positive results and go on to receive FDA approval not to just keep buying these cheap shares... 15 cants... there must be a 80% short on this thing... if they had some good news from just Europe right now a short squeeze would ensue and it would make this a 3 or 4 bagger.... as long as its not news of another conference for Lisa to waste time at. ...
Just checked it ... on the settlement date of Nov 30 the short interest was 429,304 down 43% from the previous settlement date... that was due to the expected release of the Phase III .... now the next settlement is Dec 15 lets see how much larger that number is when its posted... going to be a big increase I bet
News 
Market Data 
Discover 
AI
